No Photo Available

Last Update

2003-12-11T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong David Enscore?

Dr. David J. Enscore PhD

Manager, Development

Executive Director , Transdermal Product Development

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Executive Director , Transdermal Product Development

Background Information

Employment History

Vice President, Research and Development

Ph.D. Joins Spherics , Inc.

Senior Vice President Product Research and Development

Altea Therapeutics Corporation

Vice President of Research and Development

Micell Technologies Inc

Affiliations

Senior Scientific Advisor
4P Therapeutics LLC

Education

BS

North Carolina State University

Ph.D.

PhD

Chemical Engineering

North Carolina State University

Web References (20 Total References)


Altea Therapeutics Appoints Senior R&D Executive Dr. David J. Enscore to Lead Product Development

biz.yahoo.com [cached]

Altea Therapeutics Appoints Senior R&D Executive Dr. David J. Enscore to Lead Product DevelopmentAltea Therapeutics Appoints Senior R&D Executive Dr. David J. Enscore to Lead Product Development

...
Altea Therapeutics Appoints Senior R&D Executive Dr. David J. Enscore to Lead Product Development
...
TUCKER, Ga.--(BUSINESS WIRE)--Dec. 11, 2003--Altea Therapeutics has appointed David J. Enscore, PhD, as Senior Vice President for Product Research & Development.Dr. Enscore is responsible for leading all of the Company's pharmaceutical product research and development activities.The Company's lead clinical products are a daily insulin skin patch for treating individuals with diabetes and a hydromorphone skin patch for the controllable management of severe acute and chronic pain.
David Enscore has had an extensive career in the development of novel therapeutic products.He was previously at ALZA as Executive Director, Transdermal Product Development where he managed the development of four commercial controlled release pharmaceuticals, including NICODERM CQ (Transdermal Nicotine).More recently he was Vice President for Research & Development at Focal, Inc., responsible for the definition, development and market introduction of two surgical sealant products: FocalSeal-L and FocalSeal-S.He joins Altea Therapeutics from Spherics, Inc., a drug delivery company based in Lincoln, RI, where was President and Head of Research & Development.Dr. Enscore is an Inventor on 24 U.S. patents in drug delivery and medical devices.
"David's appointment will strengthen both our pharmaceutical development capabilities and our project management needs as we transition from a technology-based company to one developing high-value pharmaceutical products" said Eric Tomlinson, D.Sc., Ph.D., the Company's Chief Executive Officer."
...
It offers a painless alternative to needle injections while providing controllable drug delivery," said Dr. Enscore.


Leadership - 4P Therapeutics

www.4ptherapeutics.com [cached]

David Enscore, Ph.D.

Principal Scientist David J. Enscore advises 4P Therapeutics technology selection, product design goals, and analyzes results from product development studies. Over the last several years, he has provided product development direction to the pharmaceutical and medical device industries on a consulting basis. His focus is on controlled drug delivery products in general with a strong emphasis on transdermal drug delivery systems. In a consulting role, he served as Interim Vice President of R&D at Micell Technologies, a company developing a sirolimus eluting, bioabsorbable polymer coated coronary artery stent.
He has served as an expert witness in several patent litigation cases involving transdermal technology. Prior to starting his consulting business, Dr. Enscore was Senior Vice President, Product Research and Development at Altea Therapeutics and was responsible for all product development activities including pharmaceutical science, engineering, clinical R&D, quality assurance, and regulatory affairs. Before joining Altea Therapeutics, he held senior R&D positions at Spherics, Incorporated, an advanced oral drug delivery company and Focal, Incorporated, a company that developed resorbable tissue sealants.
Prior to this, Dr. Enscore worked extensively in transdermal drug delivery, in various scientific and management positions, at Alza Corporation. At Alza, he lead the development of Nicoderm® CQ (transdermal nicotine), the second generation testosterone transdermal system (Testoderm® TTS), and the Actisite® tetracycline periodontal fiber. He has been granted 25 U.S. patents in controlled drug delivery and biodegrabable polymers. Dr. Enscore received a BS and a PhD in Chemical Engineering, with a minor in Polymer Science, from North Carolina State University.


David Enscore, ...

www.4ptherapeutics.com [cached]

David Enscore, Ph.D. Senior Scientific Advisor

David J. Enscore advises 4P Therapeutics technology selection, product design goals, and analyzes results from product development studies. Over the last several years, he has provided product development direction to the pharmaceutical and medical device industries on a consulting basis. His focus is on controlled drug delivery products in general with a strong emphasis on transdermal drug delivery systems. In a consulting role, he served as Interim Vice President of R&D at Micell Technologies, a company developing a sirolimus eluting, bioabsorbable polymer coated coronary artery stent. He has served as an expert witness in several patent litigation cases involving transdermal technology. Prior to starting his consulting business, Dr. Enscore was Senior Vice President, Product Research and Development at Altea Therapeutics and was responsible for all product development activities including pharmaceutical science, engineering, clinical R&D, quality assurance, and regulatory affairs. Before joining Altea Therapeutics, he held senior R&D positions at Spherics, Incorporated, an advanced oral drug delivery company and Focal, Incorporated, a company that developed resorbable tissue sealants. Prior to this, Dr. Enscore worked extensively in transdermal drug delivery, in various scientific and management positions, at Alza Corporation. At Alza, he lead the development of Nicoderm® CQ (transdermal nicotine), the second generation testosterone transdermal system (Testoderm® TTS), and the Actisite® tetracycline periodontal fiber. He has been granted 25 U.S. patents in controlled drug delivery and biodegrabable polymers. Dr. Enscore received a BS and a PhD in Chemical Engineering, with a minor in Polymer Science, from North Carolina State University.


GeorgiaBio: Altea Therapeutics Forms Premier Scientific Advisory Board

www.gabio.org [cached]

David J. Enscore, PhD managed the commercial development of four controlled release pharmaceuticals while at ALZA, a leading drug delivery company subsequently acquired by Johnson & Johnson. He was formerly SVP Product Research and Development at Altea Therapeutics and is an inventor on 25 U.S. patents in drug delivery and medical devices.


POD Holding

www.podholding.com [cached]

David J. Enscore, Ph.D., Named Interim President of Spherics, Inc.October 2, 2002, Lincoln, Rhode Island - Spherics, Inc. today announced that David J. Enscore, Ph.D. has been named Interim President, ...

Similar Profiles

Other People with this Name

Other people with the name Enscore

Susan Enscore

Russell Enscore
Centers for Disease Control and Prevention

Michael Enscore
North Carolina Home Builders Association

Emory Enscore
Kecoughtan High School

Melody Enscore
Sage Scientific Writing LLC

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory